up and up omeprazole
NDC 11673-346, omeprazole, tablet, delayed release, from Target Corporation.
- Product NDC
- 11673-346
- Status
- Listed
- Labeler
- Target Corporation
- Dosage form
- TABLET, DELAYED RELEASE
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- NDA
- Application
- NDA022032
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/11673-346 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- OMEPRAZOLE20 mg/1
Pharmacologic classes
Cytochrome P450 2C19 Inhibitors [MoA]; Proton Pump Inhibitor [EPC]; Proton Pump Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 11673-346-03 | 11673034603 | 3 BOTTLE in 1 CARTON (11673-346-03) / 14 TABLET, DELAYED RELEASE in 1 BOTTLE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 11673-346 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/11673-346 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 11673-346. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.